Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system (CNS). Hydroxycholesterols (OHCs), metabolites of CNS cholesterol, are involved in diverse cellular responses to inflammation and demyelination, and may also be involved in the pathogenesis of NMO. We a...

Full description

Bibliographic Details
Main Authors: Eunju Cha, Kang Mi Lee, Ki Duk Park, Kyung Seok Park, Kwang-Woo Lee, Sung-Min Kim, Jaeick Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5152860?pdf=render
_version_ 1819091377132142592
author Eunju Cha
Kang Mi Lee
Ki Duk Park
Kyung Seok Park
Kwang-Woo Lee
Sung-Min Kim
Jaeick Lee
author_facet Eunju Cha
Kang Mi Lee
Ki Duk Park
Kyung Seok Park
Kwang-Woo Lee
Sung-Min Kim
Jaeick Lee
author_sort Eunju Cha
collection DOAJ
description Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system (CNS). Hydroxycholesterols (OHCs), metabolites of CNS cholesterol, are involved in diverse cellular responses to inflammation and demyelination, and may also be involved in the pathogenesis of NMO. We aimed to develop a sensitive and reliable method for the quantitative analysis of three major OHCs (24S-, 25-, and 27-OHCs), and to evaluate their concentration in the cerebrospinal fluid (CSF) and serum of patients with NMO. The levels of the three OHCs in the serum and CSF were measured using liquid chromatography-silver ion coordination ionspray tandem mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry with picolinyl ester derivatization, respectively. The linear range was 5-250 ng/mL for 24S- and 27-OHC, and 0.5-25 ng/mL for 25-OHC in serum, and was 0.1-5 ng/mL for 24S- and 27-OHC, and 0.03-1 ng/mL for 25-OHC in CSF. Precision and accuracy were 0.5%-14.7% and 92.5%-109.7%, respectively, in serum, and were 0.8%-7.7% and 94.5%-119.2%, respectively, in CSF. Extraction recovery was 82.7%-90.7% in serum and 68.4%-105.0% in CSF. When analyzed in 26 NMO patients and 23 control patients, the 25-OHC (0.54 ± 0.96 ng/mL vs. 0.09 ± 0.04 ng/mL, p = 0.032) and 27-OHC (2.68 ± 3.18 ng/mL vs. 0.68 ± 0.25 ng/mL, p = 0.005) were increased in the CSF from NMO patients. When we measured the OHCCSF index that controls the effects of blood-brain barrier disruption on the level of OHC in the CSF, the 27-OHCCSF index was associated with disability (0.723; 95% confidence interval (CI)- 0.181, 0.620; p = 0.002), while the 24-OHCCSF index (0.518; 95% CI- 1.070, 38.121; p = 0.040) and 25-OHCCSF index (0.677; 95% CI- 4.313, 18.532; p = 0.004) were associated with the number of white blood cells in the CSF of NMO patients. Our results imply that OHCs in the CNS could play a role in the pathogenesis of NMO.
first_indexed 2024-12-21T22:38:45Z
format Article
id doaj.art-1e021fae676f4d87b4009c573c6ad55e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T22:38:45Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1e021fae676f4d87b4009c573c6ad55e2022-12-21T18:47:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011112e016781910.1371/journal.pone.0167819Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.Eunju ChaKang Mi LeeKi Duk ParkKyung Seok ParkKwang-Woo LeeSung-Min KimJaeick LeeNeuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system (CNS). Hydroxycholesterols (OHCs), metabolites of CNS cholesterol, are involved in diverse cellular responses to inflammation and demyelination, and may also be involved in the pathogenesis of NMO. We aimed to develop a sensitive and reliable method for the quantitative analysis of three major OHCs (24S-, 25-, and 27-OHCs), and to evaluate their concentration in the cerebrospinal fluid (CSF) and serum of patients with NMO. The levels of the three OHCs in the serum and CSF were measured using liquid chromatography-silver ion coordination ionspray tandem mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry with picolinyl ester derivatization, respectively. The linear range was 5-250 ng/mL for 24S- and 27-OHC, and 0.5-25 ng/mL for 25-OHC in serum, and was 0.1-5 ng/mL for 24S- and 27-OHC, and 0.03-1 ng/mL for 25-OHC in CSF. Precision and accuracy were 0.5%-14.7% and 92.5%-109.7%, respectively, in serum, and were 0.8%-7.7% and 94.5%-119.2%, respectively, in CSF. Extraction recovery was 82.7%-90.7% in serum and 68.4%-105.0% in CSF. When analyzed in 26 NMO patients and 23 control patients, the 25-OHC (0.54 ± 0.96 ng/mL vs. 0.09 ± 0.04 ng/mL, p = 0.032) and 27-OHC (2.68 ± 3.18 ng/mL vs. 0.68 ± 0.25 ng/mL, p = 0.005) were increased in the CSF from NMO patients. When we measured the OHCCSF index that controls the effects of blood-brain barrier disruption on the level of OHC in the CSF, the 27-OHCCSF index was associated with disability (0.723; 95% confidence interval (CI)- 0.181, 0.620; p = 0.002), while the 24-OHCCSF index (0.518; 95% CI- 1.070, 38.121; p = 0.040) and 25-OHCCSF index (0.677; 95% CI- 4.313, 18.532; p = 0.004) were associated with the number of white blood cells in the CSF of NMO patients. Our results imply that OHCs in the CNS could play a role in the pathogenesis of NMO.http://europepmc.org/articles/PMC5152860?pdf=render
spellingShingle Eunju Cha
Kang Mi Lee
Ki Duk Park
Kyung Seok Park
Kwang-Woo Lee
Sung-Min Kim
Jaeick Lee
Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
PLoS ONE
title Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
title_full Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
title_fullStr Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
title_full_unstemmed Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
title_short Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
title_sort hydroxycholesterol levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica revealed by lc ag cis ms ms and lc esi ms ms with picolinic derivatization increased levels and association with disability during acute attack
url http://europepmc.org/articles/PMC5152860?pdf=render
work_keys_str_mv AT eunjucha hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT kangmilee hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT kidukpark hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT kyungseokpark hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT kwangwoolee hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT sungminkim hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack
AT jaeicklee hydroxycholesterollevelsintheserumandcerebrospinalfluidofpatientswithneuromyelitisopticarevealedbylcagcismsmsandlcesimsmswithpicolinicderivatizationincreasedlevelsandassociationwithdisabilityduringacuteattack